Trihexosylceramide (d18:1/24:0) is a globotriaosylceramide (Gb3) subtype with an unmodified d18:1 sphingosine moiety and a saturated C24:0 fatty acid chain, which serves as a biomarker for Fabry disease. Trihexosylceramide (d18:1/24:0) is applicable to the research of Fabry disease.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Endogenous Metabolite
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.